Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway

• Published in: Journal of translational medicine Vol. 14; no. 26; p. 26
• Main Authors: Zhao, Xiao-Peng, Zhang, Hong, Jiao, Jiu-Yang, Tang, Dong-Xiao, Wu, Yu-Ling, Pan, Chao-Bin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 27.01.2016; BioMed Central
• Subjects: Carcinogenesis - genetics; Carcinogenesis - pathology; Carcinoma, Squamous Cell - genetics; Carcinoma, Squamous Cell - pathology; Cell Line, Tumor; Cell Movement - genetics; Development and progression; Down-Regulation; Epithelial-Mesenchymal Transition - genetics; Female; Gene expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic aspects; HMGA2 Protein - genetics; HMGA2 Protein - metabolism; Humans; Kaplan-Meier Estimate; Male; Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Phenotype; Physiological aspects; Prognosis; Risk Factors; Snail Family Transcription Factors; Stem cells; Tongue cancer; Tongue Neoplasms - genetics; Tongue Neoplasms - pathology; Transcription Factors - metabolism; Up-Regulation - genetics; China
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-016-0777-0

Metastasis to long distance organs is the main reason leading to morality of tongue squamous cell carcinoma (TSCC); however, the molecular mechanisms are still unknown. High mobility group AT-hook 2 (HMGA2) is highly expressed in multiple metastatic carcinomas, in which it contributes to cancer progression, metastasis and poor prognosis by upregulating Snail expression and inducing epithelial mesenchymal transition (EMT). This study focuses on investigating the role and mechanism of regulation of HMGA2 in the metastasis of TSCC. HMGA2 mRNA and protein expression were examined in TSCC specimens by quantitative real-time polymerase chain reaction, western blotting and immunohistochemistry (IHC). Western blotting, IHC and immunofluorescence were also used to measure the expression and localization of EMT marker E-Cadherin and Vimentin both in TSCC cells and tissues. Knockdown assay was performed in vitro in TSCC cell lines using small interfering RNAs and the functional assay was carried out to determine the role of HMGA2 in TSCC cell migration and invasion. TSCC mRNA and protein expression were significantly up-regulated in tumor tissues when compared to adjacent non-tumor tissues, and the overexpression of HMGA2 was closely correlated with lymph nodes metastasis. Clinicopathological analysis indicated that HMGA2 expression was associated with clinical stage (P = 0.001), lymph node metastasis (P = 0.000), histological differentiation (P = 0.002) and survival (P = 0.000). Silencing the HMGA2 expression in Cal27 and UM1 resulted in the inhibition of cell migration and invasion, meanwhile down-regulation of HMGA2 impaired the phenotype of EMT in TSCC cell lines and tissues. The Multivariate survival analysis indicates that HMGA2 can be an independent prognosis biomarker in TSCC. Our findings demonstrate that HMGA2 promotes TSCC invasion and metastasis; additionally, HMGA2 is an independent prognostic factor which implied that HMGA2 can be a biomarker both for prognosis and therapeutic target of TSCC.